OrbiMed’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Sell |
9,200
-14,300
| -61% | -$1.97M | 0.03% | 87 |
|
|
2025
Q1 | $4.24M | Hold |
23,500
| – | – | 0.1% | 78 |
|
|
2024
Q4 | $3.68M | Hold |
23,500
| – | – | 0.08% | 88 |
|
|
2024
Q3 | $4.28M | Sell |
23,500
-6,466
| -22% | -$1.18M | 0.08% | 96 |
|
|
2024
Q2 | $5.5M | Sell |
29,966
-7,200
| -19% | -$1.32M | 0.11% | 84 |
|
|
2024
Q1 | $6.61M | Sell |
37,166
-66,534
| -64% | -$11.8M | 0.12% | 91 |
|
|
2023
Q4 | $12.9M | Buy |
+103,700
| New | +$12.9M | 0.26% | 70 |
|
|
2020
Q1 | – | Sell |
-994,808
| Closed | -$55.1M | – | 150 |
|
|
2019
Q4 | $55.1M | Buy |
994,808
+392,858
| +65% | +$21.8M | 0.79% | 41 |
|
|
2019
Q3 | $20.9M | Sell |
601,950
-40,056
| -6% | -$1.39M | 0.4% | 61 |
|
|
2019
Q2 | $25.9M | Buy |
642,006
+582,796
| +984% | +$23.5M | 0.4% | 58 |
|
|
2019
Q1 | $1.95M | Buy |
+59,210
| New | +$1.95M | 0.03% | 110 |
|